The incidence of bacterial conjunctivitis and the antibacterial activity of drugs in their treatment
Authors: Konovalova N., Molodaya A., Dolenko L., Kovtun A., Yurchenko L., Rybalko A., The Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine, Odessa, Ukraine
Frequency of bacterial conjunctivitis and antibacterial activity of drugs in their treatment. Bacterial conjunctivitis is the cause of frequent referral to an ophthalmologist. They are characterized by seasonality, sharpness of the current, decrease and loss of working capacity and high invasiveness. The urgency of the problem is due to the growing resistance to antibacterial drugs in ophthalmic practice.
To analyze the frequency of occurrence, antibiotic resistance antibacterial activity of drugs in the treatment of bacterial conjunctivitis on the basis of data analysis for 2019.
The analysis of 346 (692 eyes) bacteriological studies of biological material in order to study the etiological factors of inflammatory diseases of the eyes, to assess the state of sensitivity of microorganisms to modern antibiotics.
A study we conducted in 2019 showed Gram-positive flora in 97.3% of patients. Fungal flora – in 3 patients (0.86%). Allocation of gram-negative flora – 4 people (1.1%). It is established that the most effective antibacterial drugs are: Levoxymed (for epidermal, Staphylococcus aureus, Escherichia coli, streptococcal infection, moracella), Medetrom (for hemolytic staphylococcus) and Floximed (for enterococci).
Keywords: bacterial flora, resistance, Levoksimed, Phloximed, Medetrom.
Article in PDF
View